| Name | Title | Contact Details |
|---|
UWSystems is a Auburn, CA-based company in the Business Services sector.
Wellstar Health System is a prominent not-for-profit healthcare organization based in Georgia. Established in 1993, it has grown to become the states largest and most integrated healthcare provider, operating 11 hospitals and over 250 healthcare sites across North and West Georgia. Wellstar is dedicated to improving health and well-being through its PeopleCare philosophy, which emphasizes patient-centered treatment. The organization offers a wide range of services, including specialized care in over 100 medical fields such as orthopedics, cardiology, neurology, and cancer care. Wellstars Kennestone Regional Medical Center features one of the busiest emergency departments in the U.S., which is expanding to accommodate more patients. Additionally, Wellstar provides 24/7 virtual urgent care and telehealth services. Committed to community health, Wellstar allocates significant resources to charity care and partners with other institutions to enhance access to healthcare services.
La Follette Johnson De Haas Fesler Silberberg is one of the leading companies in Business Services industry. La Follette Johnson De Haas Fesler Silberberg is based in Santa Ana, CA. You can find more information on La Follette Johnson De Haas Fesler Silberberg at www.ljdfa.com
The Premier Group is a White Plains, NY-based company in the Business Services sector.
Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos` lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.